Sanford Burnham Prebys Cancer Center

One of only seven National Cancer Institute (NCI)-designated cancer centers in the nation.
NCI-Designated Cancer Center

Taking aim at cancer

“There have been so many advances in genomics, immunology, genetic engineering and information science—now is the time to use these advances to speed the progress against cancer.”

Garth Powis, D.Phil., Center Director

Director's Statement

 

Achieving our goals through collaboration

Our scientists are always looking for novel ideas, partners and new ways of doing groundbreaking research to target cancer.

Programs

Tumor Initiation and Maintenance Program

Understanding the cells that give rise to tumors and the signals allowing them to expand uncontrollably will help us learn how to defeat cancer.

Learn More

Cancer, Molecules and Structures Program

Insights into the complex system of networks and mechanisms that tumors use to survive and proliferate will lead us to tumor-specific, less toxic therapies.

Learn More

Tumor Microenvironment and Cancer Immunology Program

We are studying the interplay among cancer cells, immune cells and their environment to put the brakes on cancer.
 

Learn More

Latest news

Cancer Center brochure

Learn more about the Cancer Center in our newly updated brochure.

Read More

Publications

BI1071, a Novel Nur77 Modulator, Induces Apoptosis of Cancer Cells by Activating the Nur77-Bcl-2 Apoptotic Pathway.

Chen X, Cao X, Tu X, Alitongbieke G, Xia Z, Li X, Chen Z, Yin M, Xu D, Guo S, Li Z, Chen L, Zhang X, Xu D, Gao M, Liu J, Zeng Z, Zhou H, Su Y, Zhang XK

Mol Cancer Ther 2019 May ;18(5):886-899

The histone chaperone HIRA promotes the induction of host innate immune defences in response to HSV-1 infection.

McFarlane S, Orr A, Roberts APE, Conn KL, Iliev V, Loney C, da Silva Filipe A, Smollett K, Gu Q, Robertson N, Adams PD, Rai TS, Boutell C

PLoS Pathog 2019 Mar ;15(3):e1007667

Ubiquitin Ligases in Cancer Immunotherapy - Balancing Antitumor and Autoimmunity.

Fujita Y, Tinoco R, Li Y, Senft D, Ronai ZA

Trends Mol Med 2019 May ;25(5):428-443